The most widely accepted theory of how estrogen influences estrogen receptor (ER)-positive BC is that estrogen stimulates tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer by acting through the ER. The gene discussed is ESR1; the disease is breast cancer.